Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues

Journal of Medicinal Chemistry

Volumn 56, Issue 7, 2013, Pages 2948-2958

  Zhang, Yi ^a   Albohy, Amgad ^a   Zou, Yao ^a   Smutova, Victoria ^b,c   Pshezhetsky, Alexey V ^b,c   Cairo, Christopher W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; N ACETYLNEURAMINIC ACID DERIVATIVE; NEURAMINIDASE 1; NEURAMINIDASE 2; NEURAMINIDASE 3; NEURAMINIDASE 4; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; HUMAN;

ENZYME INHIBITORS; HUMANS; ISOENZYMES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84876279046     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301892f     Document Type: Article

References (63)

1. Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Stanley, P.; Bertozzi, C. R.; Hart, G. W.; Etzler, M. E. Essentials of Glycobiology, 2 nd ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009.
2. Dwek, R. A. Glycobiology: toward understanding the function of sugars Chem. Rev. 1996, 96, 683-720
3. Culyba, E. K.; Price, J. L.; Hanson, S. R.; Dhar, A.; Wong, C. H.; Gruebele, M.; Powers, E. T.; Kelly, J. W. Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns Science 2011, 331, 571-575
4. Tauber, R.; Park, C. S.; Becker, A.; Geyer, R.; Reutter, W. Rapid intramolecular turnover of N-linked glycans in plasma membrane glycoproteins-extension of intramolecular turnover to the core sugars in plasma membrane glycoproteins of hepatoma Eur. J. Biochem. 1989, 186, 55-62
5. Tauber, R.; Park, C. S.; Reutter, W. Intramolecular heterogeneity of degradation in plasma membrane glycoproteins-evidence for a general characteristic Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 4026-4029
6. Parker, R. B.; Kohler, J. J. Regulation of intracellular signaling by extracellular glycan remodeling ACS Chem. Biol. 2010, 5, 35-46
7. Pshezhetsky, A. V.; Hinek, A. Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors Glycoconjugate J. 2011, 28, 441-452
8. Gloster, T. M.; Vocadlo, D. J. Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology Nat. Chem. Biol. 2012, 8, 683-694
9. Goi, G.; Bairati, C.; Massaccesi, L.; Lovagnini, A.; Lombardo, A.; Tettamanti, G. Membrane anchoring and surface distribution of glycohydrolases of human erythrocyte membranes FEBS Lett. 2000, 473, 89-94
10. Aureli, M.; Masilamani, A. P.; Illuzzi, G.; Loberto, N.; Scandroglio, F.; Prinetti, A.; Chigorno, V.; Sonnino, S. Activity of plasma membrane beta-galactosidase and beta-glucosidase FEBS Lett. 2009, 583, 2469-2473
11. Porwoll, S.; Loch, N.; Kannicht, C.; Nuck, R.; Grunow, D.; Reutter, W.; Tauber, R. Cell surface glycoproteins undergo postbiosynthetic modification of their N -glycans by stepwise demannosylation J. Biol. Chem. 1998, 273, 1075-1085
12. Cordero, O. J.; Merino, A.; de la Cadena, M. P.; Bugía, B.; Nogueira, M.; Viñuela, J. E.; Martínez-Zorzano, V. S.; de Carlos, A.; Rodríguez-Berrocal, F. J. Cell surface human alpha- l -fucosidase Eur. J. Biochem. 2001, 268, 3321-3331
13. Monti, E.; Bonten, E.; D'Azzo, A.; Bresciani, R.; Venerando, B.; Borsani, G.; Schauer, R.; Tettamanti, G. Sialidases in Vertebrates: A Family of Enzymes Tailored for Several Cell Functions. In Advances in Carbohydrate Chemistry and Biochemistry, Academic Press: New York, 2010; Vol. 64, pp 403-479.
14. Feng, C.; Zhang, L.; Almulki, L.; Faez, S.; Whitford, M.; Hafezi-Moghadam, A.; Cross, A. S. Endogenous PMN sialidase activity exposes activation epitope on CD11b/CD18 which enhances its binding interaction with ICAM-1 J. Leukocyte Biol. 2011, 90, 313-321
15. Stamatos, N. M.; Carubelli, I.; van de Vlekkert, D.; Bonten, E. J.; Papini, N.; Feng, C. G.; Venerando, B.; d'Azzo, A.; Cross, A. S.; Wang, L. X.; Gomatos, P. J. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity J. Leukocyte Biol. 2010, 88, 1227-1239
16. Nan, X.; Carubelli, I.; Stamatos, N. M. Sialidase expression in activated human T lymphocytes influences production of IFN-γ J. Leukocyte Biol. 2007, 81, 284-296
17. Yamaguchi, K.; Shiozaki, K.; Moriya, S.; Koseki, K.; Wada, T.; Tateno, H.; Sato, I.; Asano, M.; Iwakura, Y.; Miyagi, T. Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase PLoS One 2012, 7, e41132
18. Miyagi, T. Mammalian sialidases and their functions Trends Glycosci. Glycotechnol. 2010, 22, 162-172
19. Miyagi, T.; Yamaguchi, K. Mammalian sialidases: physiological and pathological roles in cellular functions Glycobiology 2012, 22, 880-896
20. Cherayil, G. D. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis J. Neurol. Sci. 1984, 63, 1-10
21. Stelmasiak, Z.; Solski, J.; Jakubowska, B. Sialic acids in serum and erythrocyte membranes in patients with MS Neuropsychiatrie 1996, 10, 205-208
22. Cantarel, B. L.; Coutinho, P. M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B. The carbohydrate-active enzymes database (CAZy): an expert resource for glycogenomics Nucleic Acids Res. 2009, 37, D233-D238
23. Monti, E.; Preti, A.; Venerando, B.; Borsani, G. Recent development in mammalian sialidase molecular biology Neurochem. Res. 2002, 27, 649-663
24. Lukong, K. E.; Seyrantepe, V.; Landry, K.; Trudel, S.; Ahmad, A.; Gahl, W. A.; Lefrancois, S.; Morales, C. R.; Pshezhetsky, A. V. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail J. Biol. Chem. 2001, 276, 46172-46181
25. Vinogradova, M. V.; Michaud, L.; Mezentsev, A. V.; Lukong, K. E.; El-Alfy, M.; Morales, C. R.; Potier, M.; Pshezhetsky, A. V. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation Biochem. J. 1998, 330, 641-650
26. Monti, E.; Preti, A.; Rossi, E.; Ballabio, A.; Borsani, G. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases Genomics 1999, 57, 137-143
27. Miyagi, T.; Tsuiki, S. Purification and characterization of cytosolic sialidase from rat liver J. Biol. Chem. 1985, 260, 6710-6716
28. Tringali, C.; Papini, N.; Fusi, P.; Croci, G.; Borsani, G.; Preti, A.; Tortora, P.; Tettamanti, G.; Venerando, B.; Monti, E. Properties of recombinant human cytosolic sialidase HsNEU2. The enzyme hydrolyzes monomerically dispersed GM1 ganglioside molecules J. Biol. Chem. 2004, 279, 3169-79
29. Wang, Y.; Yamaguchi, K.; Wada, T.; Hata, K.; Zhao, X. J.; Fujimoto, T.; Miyagi, T. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains J. Biol. Chem. 2002, 277, 26252-26259
30. Zanchetti, G.; Colombi, P.; Manzoni, M.; Anastasia, L.; Caimi, L.; Borsani, G.; Venerando, B.; Tettamanti, G.; Preti, A.; Monti, E.; Bresciani, R. Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures Biochem. J. 2007, 408, 211-219
31. Yamaguchi, K.; Hata, K.; Koseki, K.; Shiozaki, K.; Akita, H.; Wada, T.; Moriya, S.; Miyagi, T. Evidence for mitochondrial localization of a novel human sialidase (NEU4) Biochem. J. 2005, 390, 85-93
32. Monti, E.; Bassi, M. T.; Bresciani, R.; Civini, S.; Croci, G. L.; Papini, N.; Riboni, M.; Zanchetti, G.; Ballabio, A.; Preti, A.; Tettamanti, G.; Venerando, B.; Borsani, G. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family Genomics 2004, 83, 445-453
33. Seyrantepe, V.; Landry, K.; Trudel, S.; Hassan, J. A.; Morales, C. R.; Pshezhetsky, A. V. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells J. Biol. Chem. 2004, 279, 37021-37029
34. Seyrantepe, V.; Poupetova, H.; Froissart, R.; Zabot, M. T.; Maire, I.; Pshezhetsky, A. V. Molecular pathology of NEU1 gene in sialidosis Hum. Mutat. 2003, 22, 343-352
35. Wang, P.; Zhang, J.; Bian, H.; Wu, P.; Kuvelkar, R.; Kung, T. T.; Crawley, Y.; Egan, R. W.; Billah, M. M. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor Biochem. J. 2004, 380, 425-433
36. Sandbhor, M. S.; Soya, N.; Albohy, A.; Zheng, R. B.; Cartmell, J.; Bundle, D. R.; Klassen, J. S.; Cairo, C. W. Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone Biochemistry 2011, 50, 6753-6762
37. Li, Y.; Cao, H.; Yu, H.; Chen, Y.; Lau, K.; Qu, J.; Thon, V.; Sugiarto, G.; Chen, X. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies Mol. BioSyst. 2011, 7, 1060-1072
38. Khedri, Z.; Li, Y.; Cao, H.; Qu, J.; Yu, H.; Muthana, M. M.; Chen, X. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2 Org. Biomol. Chem. 2012, 10, 6112-6120
39. Magesh, S.; Moriya, S.; Suzuki, T.; Miyagi, T.; Ishida, H.; Kiso, M. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1) Bioorg. Med. Chem. Lett. 2008, 18, 532-537
40. Li, J.; Zheng, M.; Tang, W.; He, P.-L.; Zhu, W.; Li, T.; Zuo, J.-P.; Liu, H.; Jiang, H. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities Bioorg. Med. Chem. Lett. 2006, 16, 5009-5013
41. von Itzstein, M.; Wu, W.-Y.; Jin, B. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl- N -acetylneuraminic acid: a potent influenza virus sialidase inhibitor Carbohydr. Res. 1994, 259, 301-305
42. Lu, Y.; Gervay-Hague, J. Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds Carbohydr. Res. 2007, 342, 1636-1650
43. Meindl, P.; Tuppy, H. 2-Deoxy-2,3-dehydro-sialinsäuren, 3. Mitt.: Hemmung der Vibrio cholerae -neuraminidase durch oxidationsprodukte der 2-deoxy-2,3-dehydro- N -acetylneuraminsäure Monatsh. Chem. 1970, 101, 639-647
44. Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Cobley, K. N.; Taylor, H.; Whittington, A. R.; Scicinski, J.; Bethell, R. C.; Taylor, N.; Skarzynski, T.; Cleasby, A.; Singh, O.; Wonacott, A.; Varghese, J.; Colman, P. Novel inhibitors of influenza sialidases related to GG167: structure-activity, crystallographic and molecular dynamic studies with 4 H -pyran-2-carboxylic acid 6-carboxamides Bioorg. Med. Chem. Lett. 1996, 6, 2931-2936
45. Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Starkey, I. D.; Cobley, K. N.; Weston, H.; Scicinski, J.; Merritt, A.; Whittington, A.; Wyatt, P.; Taylor, N.; Green, D.; Bethell, R.; Madar, S.; Fenton, R. J.; Morley, P. J.; Pateman, T.; Beresford, A. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4 H -pyran-6-carboxamides J. Med. Chem. 1998, 41, 787-797
46. Sollis, S. L.; Smith, P. W.; Howes, P. D.; Cherry, P. C.; Bethell, R. C. Novel inhibitors of influenza sialidase related to GG167 synthesis of 4-amino and guanidino-4 H -pyran-2-carboxylic acid-6-propylamides. Selective inhibitors of influenza A virus sialidase Bioorg. Med. Chem. Lett. 1996, 6, 1805-1808
47. Politzer, P.; Murray, J. S. Some Intrinsic Features of Hydroxylamines, Oximes and Hydroxamic Acids: Integration of Theory and Experiment. In The Chemistry of Hydroxylamines, Oximes and Hydroxamic Acids; John Wiley & Sons, Ltd.: Chichester, U.K., 2008; pp 1-27.
48. Pshezhetsky, A. V.; Potier, M. Association of N -acetylgalactosamine-6- sulfate sulfatase with the multienzyme lysosomal complex of β- galactosidase, cathepsin A, and neuraminidase J. Biol. Chem. 1996, 271, 28359-28365
49. Watson, D. C.; Leclerc, S.; Wakarchuk, W. W.; Young, N. M. Enzymatic synthesis and properties of glycoconjugates with legionaminic acid as a replacement for neuraminic acid Glycobiology 2010, 21, 99-108
50. Albohy, A.; Li, M. D.; Zheng, R. B.; Zou, C.; Cairo, C. W. Insight into substrate recognition and catalysis by the mammalian neuraminidase 3 (NEU3) through molecular modeling and site directed mutagenesis Glycobiology 2010, 20, 1127-1138
51. Albohy, A.; Mohan, S.; Zheng, R. B.; Pinto, B. M.; Cairo, C. W. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes Bioorg. Med. Chem. 2011, 19, 2817-22
52. Chavas, L. M. G.; Tringali, C.; Fusi, P.; Venerando, B.; Tettamanti, G.; Kato, R.; Monti, E.; Wakatsuki, S. Crystal structure of the human cytosolic sialidase Neu2-evidence for the dynamic nature of substrate recognition J. Biol. Chem. 2005, 280, 469-475
53. Zou, Y.; Albohy, A.; Sandbhor, M.; Cairo, C. W. Inhibition of human neuraminidase 3 (NEU3) by C 9-triazole derivatives of 2,3-didehydro- N -acetyl-neuraminic acid Bioorg. Med. Chem. Lett. 2010, 20, 7529-7533
54. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: applications of AutoDock J. Mol. Recognit. 1996, 9, 1-5
55. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 1998, 19, 1639-1662
56. von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors Nat. Rev. Drug Discovery 2007, 6, 967-974
57. Hata, K.; Koseki, K.; Yamaguchi, K.; Moriya, S.; Suzuki, Y.; Yingsakmongkon, S.; Hirai, G.; Sodeoka, M.; Von Itzstein, M.; Miyagi, T. Limited inhibitory effects of oseltamivir and zanamivir on human sialidases Antimicrob. Agents Chemother. 2008, 52, 3484-3491
58. Chavas, L. M. G.; Kato, R.; Suzuki, N.; von Itzstein, M.; Mann, M. C.; Thomson, R. J.; Dyason, J. C.; McKimm-Breschkin, J.; Fusi, P.; Tringali, C.; Venerando, B.; Tettamanti, G.; Monti, E.; Wakatsuki, S. Complexity in influenza virus targeted drug design: interaction with human sialidases J. Med. Chem. 2010, 53, 2998-3002
59. Magesh, S.; Suzuki, T.; Miyagi, T.; Ishida, H.; Kiso, M. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors J. Mol. Graphics Modell. 2006, 25, 196-207
60. Bashiardes, G.; Bodwell, G. J.; Davies, S. G. Asymmetric synthesis of (-)-actinonin and (-)-epi-actinonin J. Chem. Soc., Perkin Trans. 1 1993, 459-469
61. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics J. Am. Chem. Soc. 1990, 112, 6127-6129
62. The PyMOL Molecular Graphics System, version 1.5.0.4; Schrodinger, LLC: New York; http://www.pymol.org/ (accessed November 15, 2012).
63. Gilson, M. K.; Sharp, K. A.; Honig, B. H. Calculating the electrostatic potential of molecules in solution: method and error assessment J. Comput. Chem. 1988, 9, 327-335